India Pharma Chiefs On Future Manufacturing Networks And Specter Of Tariffs

 
• By Anju Ghangurde

CEOs of top Indian firms discuss how policies and geopolitics could shape future manufacturing networks and also the simmering issue of tariffs. US President Donald Trump has just reiterated plans for reciprocal tariffs at a joint session of Congress.

IPA CEO panel
L-R: Sathya Prathipati - senior partner and lead, Asia Life Sciences, McKinsey & Co; Umang Vohra, MD and global CEO, Cipla; Nilesh Gupta, MD, Lupin; Dilip Shanghvi, Founder & MD, Sun Pharmaceutical Industries; Pankaj Patel, Chairman, Zydus Lifesciences

More from India

More from Digital Technologies